Cambridge Antibody Technology Group PLC
5 Year Summary P&L with Balance Sheet
| 30 September | 2001 | 2002 | 2003 | 2004 | 2005 | |
|---|---|---|---|---|---|---|
| turnover | £m |  |
|
8.74 | 15.9 | 194 |
| pre tax profit | £m | |
|
(41.8) | (38.1) | (0.53) |
| norm earn per share | p | |
|
(107) | (93.3) | (6.16) |
| FRS3 earn per share | p | |
|
(108) | (93.3) | (3.20) |
| div per share | p | |
|
- | - | - |
| intangibles | £m | |
|
6.88 | 5.83 | 2.58 |
| fixed assets | £m | |
|
14.4 | 12.4 | 11.7 |
| fixed investments | £m | |
|
3.37 | 2.94 | 2.30 |
| stocks | £m | |
|
- | - | - |
| debtors | £m | |
|
4.53 | 4.46 | 14.6 |
| cash, securities | £m | |
|
109 | 95.7 | 177 |
| creditors short | £m | |
|
12.7 | 15.6 | 29.8 |
| creditors long | £m | |
|
18.2 | 20.7 | 18.6 |
| prefs, minorities | £m | |
|
- | - | - |
| ord cap, reserves | £m | |
|
108 | 85.1 | 159 |
| mkt capitalisation | £m | |
|
187 | 256 | 384 |
2nd May 2006